ROR alpha and REV-ERB alpha are Associated With Clinicopathological Parameters and are Independent Biomarkers of Prognosis in Gastric Cancer

Xiaoshan Wang,Ru Jia,Ke Chen,Jingjing Wang,Kai Jiang,Zhengguang Wang
DOI: https://doi.org/10.1177/15330338211039670
2021-01-01
Technology in Cancer Research & Treatment
Abstract:Retinoid-related orphan receptor alpha (ROR alpha) and nuclear receptor subfamily 1 group D member 1 (REV-ERB alpha) play critical roles in many human cancers. Whether ROR alpha and REV-ERB alpha expression levels are associated with clinical characteristics are poorly understood, and they may be independent predictors of overall survival (OS) and progression-free survival (PFS) in gastric cancer (GC). This study aimed to investigate the correlation of ROR alpha and REV-ERB alpha expression levels with clinicopathological parameters, OS, and PFS in GC. Immunohistochemistry and quantitative reverse transcription-polymerase chain reaction (qRT-PCR) were employed to assess the expression levels of ROR alpha and REV-ERB alpha, which were downregulated in GC tissues compared with normal gastric tissues (P<.001; P<.001) and were associated with several clinicopathological parameters, including histological grade (P=.032; P<.001), preoperative carcinoembryonic antigen (CEA) levels (P=.004; P<.001), and tumor-node-metastasis (TNM) stage (P=.015; P<.001). Additionally, low ROR alpha and REV-ERB alpha expression levels were associated with poor OS and PFS in GC patients, respectively (P<.001; P=.001). Furthermore, univariate Cox regression model analysis showed that histological grade (P<.001; P<.001), preoperative CEA levels (P<.001; P=.001), TNM stage (P<.001; P<.001), lymph node metastasis (P=.002; P=.002), ROR alpha expression levels (P=.001; P<.001), and REV-ERB alpha expression levels (P<.001; P=.001) were associated with OS and PFS in GC. Multivariate Cox regression model analysis indicated that ROR alpha expression levels and REV-ERB alpha expression levels are independent factors of OS and PFS in GC. Besides, ROR alpha and REV-ERB alpha expression may be positively correlated (chi(2)=6.835; P=.009), and GC patients with both high ROR alpha and REV-ERB alpha expression levels had the best prognosis. In conclusion, ROR alpha and REV-ERB alpha may coparticipate in tumor activities and show potential to estimate the prognosis of GC.
What problem does this paper attempt to address?